期刊
LIFE-BASEL
卷 11, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/life11040354
关键词
convalescent plasma; COVID-19; hyperimmune plasma; SARS-CoV-2; therapy
In this narrative review, the critical analysis focuses on three factors, known as pillars, crucial in determining the clinical effectiveness of this biologic therapy: convalescent plasma, the disease COVID-19, and the patients.
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread rapidly around the world in the last year causing the coronavirus disease 2019 (COVID-19), which still is a severe threat for public health. The therapeutic management of COVID-19 is challenging as, up until now, no specific and efficient pharmacological therapy has been validated. Translating the experience from previous viral epidemics, passive immunotherapy by means of plasma from individuals recovered from COVID-19 has been intensively investigated since the beginning of the pandemic. In this narrative review, we critically analyze the three factors, named pillars, that play a key role in determining the clinical effectiveness of this biologic therapy: the convalescent plasma, the disease (COVID-19), and the patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据